Biocept Microfluidic Technology Wins USPTO Patent
The US patent 7,695,956, entitled ‘Device for Cell Separation and Analysis and Method of Using,’ protects Biocept’s microflow device to isolate cells from a bodily fluid using a
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.